Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase NA 1

Status

Completed 3Unknown 2Terminated 1Recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Vomiting 1Recovery 1Neoplasms 1Nausea 1Head and Neck Neoplasms 1

Interventions

Cyclophosphamide 1492Cisplatin 1414Paclitaxel 1317Radiotherapy 1261Carboplatin 1250Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 680Etoposide 678Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 420

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Interventional × Injections, Intravenous × Clear all
NCT04902027 2024-03-07

A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Recurrent/Metastatic Head and Neck Cancers

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 1 Completed
45 enrolled
Head & Neck

Head and Neck Neoplasms

NCT05435911 2023-01-13

Comparison of Recovery From General Anesthesia in Remimazolam With Flumazenil vs. Propofol

Seoul National University Hospital

Phase NA Completed
66 enrolled

Recovery

NCT02563951 2016-01-08

Study of Granisetron Hydrochloride Nasal Spray (GNS) in Healthy Volunteers

Maxinase Life Sciences Ltd.

Phase 1 Completed
50 enrolled

Nausea, Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡